The present invention involves the administration of Copolymer 1 (glatiramer acetate) to treat inflammatory, non-autoimmune central nervous system (CNS) diseases, alleviate the symptoms thereof, inhibit the activity of matrix metalloproteinases and suppress cytokine production by T lymphocytes.

 
Web www.patentalert.com

< Arrangement for monitoring the power delivery of a photon channeling element

< Radio frequency enabled control of environmental zones

> Neural network device for evolving appropriate connections

> Breathing assistance apparatus

~ 00256